Loading clinical trials...

Verapamil vs Steroid to Prevent Keloid Recurrence | Clinical Trials | Clareo Health

TERMINATEDPHASE4

Verapamil vs Steroid to Prevent Keloid Recurrence

Assessment of Verapamil as an Adjunct for Prevention of Keloid Recurrence After Surgical Removal

NCT01720056•The University of Western Australia

Summary

Keloid scarring is a severe cosmetic and painful disease of the skin. The gold standard treatment is yet to be clarified. This randomized clinical pilot study will compare the effects of two local treatments for preventing keloid recurrence after surgical removal; steroid and verapamil. Study hypothesis: Intralesional therapy with the calcium antagonist verapamil has equal treatment efficacy as steroid injection.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patient undergoing surgical removal of keloid
•Patient 18 years old or greater
•Length of excisional scar after surgical removal of keloid between 2 and 10 cm

Exclusion Criteria

•Keloid in face or hands
•Pregnancy or lactation
•Dementia
•Any heart or pulmonary condition
•Systemic treatment with beta-blockers, ACE-inhibitors or calcium antagonists
•Systemic corticosteroidal therapy
•Intralesional steroid treatment within 2 months of surgery to remove keloid
•Flap surgery
•Lesions to face, hands and other cosmetically sensitive areas

Locations (1)

Royal Perth Hospital

Perth, Western Australia, Australia

Key Dates

Start Date

October 1, 2012

Primary Completion Date

March 1, 2014

Completion Date

March 1, 2014

Last Updated

June 10, 2015

Enrollment

ACTUAL participants

Conditions

Keloid Scars

Interventions

Verapamil

DRUG

Kenalog 10

DRUG

Topical Cryotherapy and Keloid/Hypertrophic Scars

NCT07336368

Keloid ScarsHypertrophic Scars

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 10, 2015Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions